Mildrede Bonglack, MD
NPI 1134612013 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · Fresno, CA
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1134612013
- Entity type
- Individual
- Primary specialty
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- A204492 (CA)
Specialties & taxonomies
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary207VF0040XLicense A204492 (CA)
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
8 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
2 documented practice locations
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 34 | 16 |
| Solifenacin Succinate | 24 | 12 |
| Oxycodone Hcl | 23 | 23 |
| Ondansetron Hcl | 20 | 20 |
| Tramadol Hcl | 19 | 18 |
| Methenamine Hippurate | 17 | 16 |
| Ibuprofen | 15 | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$545 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 797 W Childs AveMerced, CA 95341-6805Phone: (209) 384-6498Fax: (209) 359-2045
Registry dates
- Enumerated
- 2018-06-14
- Last updated
- 2026-01-02
- Certified
- 2026-01-02
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.